Neurology
Conference Coverage
Migraine associated with more severe disability in patients with MS
DALLAS – “Traditional migraine risk factors such as obesity, anxiety, and depression were also overrepresented in our cohort” of patients with MS...
Conference Coverage
Incidence of treated depression nearly 100% higher in patients with MS
DALLAS – Patients with multiple sclerosis have a higher incidence of new treated depression, compared with matched patients without MS, according...
Conference Coverage
Large survey reveals that few MS patients have long-term care insurance
DALLAS – The findings suggest that clinical care teams should initiate early discussions of possible long-term needs with their patients.
Conference Coverage
Myositis mimics: Clues for making the right diagnosis
A number of conditions can mimic myositis, but clues that can point to the correct diagnosis are often present in cases involving the mimics.
Conference Coverage
Spinal cord atrophy found to be accelerated in subset of RRMS patients
DALLAS – The finding marks the first of its kind.
Conference Coverage
Noncardiac surgery has 7% covert stroke rate in elderly
HONOLULU – Covert strokes were linked with a doubled rate of cognitive decline in older patients after noncardiac surgery.
News
Does adherence to a Mediterranean diet reduce the risk of Parkinson’s disease?
Greater adherence to a Mediterranean diet is associated with lower probability of prodromal Parkinson’s disease, but questions about this...
Conference Coverage
Vaccination and antiviral treatment do not affect stroke risk following shingles
HONOLULU – Preventing shingles through vaccination might be the best method for preventing shingles-associated acute...
News
International survey probes oxygen’s efficacy for cluster headache
Oxygen is a highly effective therapy with few complications, according to a survey of patients with cluster headache.
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
News from the FDA/CDC
FDA issues warnings to companies selling illegal Alzheimer’s treatments
The FDA targeted more than 58 products.